To Test for Photo Allergy Reaction of Sunscreens

Photoallergy Clinical Trial

Official title:
A Randomized Study to Assess the Potential for Photoallergy of SPF 50 Y65 110, SPF 50 Y51 002 and SPF 15 V27 104 in Human Subjects

Status Completed

Clinical Trial Summary

The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A and UVB.

The secondary objective aims for evaluation of the safety of SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with ultraviolet (UV) A/B irradiation by monitoring adverse events (AEs) throughout the study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02872220
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	N/A
Start date	March 23, 2015
Completion date	May 8, 2015

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT03812887` - Photopatch Test Study (POST Study)
	Completed	`NCT03899064` - Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream	Phase 1